Literature DB >> 15793877

Screening differentially expressed genes in mouse hepatocarcinoma ascites cell line with high potential of lymphatic metastasis.

Xiao-Nan Cui1, Jian-Wu Tang, Li Hou, Bo Song, Li Li, Ji-Wei Liu.   

Abstract

AIM: To screen genes differentially expressed in mouse hepatocarcinoma ascites cell line with high potential of lymphatic metastasis.
METHODS: A subtracted cDNA library of mouse hepatocarcinoma cell line with high potential of lymphatic metastatic Hca-F and its synogenetic cell line Hca-P with a low metastatic potential was constructed by suppression subtracted hybridization(SSH) method. The screened clones of the subtracted library were sequenced and GeneBank homology search was performed.
RESULTS: Fourteen differentially expressed cDNA fragments of Hca-F were obtained with two novel genes.
CONCLUSION: SSH is a useful technique to detect differentially expressioned genes and an effective method to clone novel genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793877      PMCID: PMC4305887          DOI: 10.3748/wjg.v11.i12.1837

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Continuous protein synthesis is required to maintain the probability of entry into S phase.

Authors:  R F Brooks
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

2.  A model for gene therapy of human hereditary lymphedema.

Authors:  M J Karkkainen; A Saaristo; L Jussila; K A Karila; E C Lawrence; K Pajusola; H Bueler; A Eichmann; R Kauppinen; M I Kettunen; S Yla-Herttuala; D N Finegold; R E Ferrell; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

3.  Cloning and analysis of the human S13 ribosomal protein cDNA.

Authors:  C Chadéneau; B LeMoullac; M G Denis
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

4.  Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells.

Authors:  K Ohtani; H Sakamoto; T Rutherford; Z Chen; K Satoh; F Naftolin
Journal:  Cancer Lett       Date:  1999-12-01       Impact factor: 8.679

Review 5.  Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.

Authors:  M J Karkkainen; T V Petrova
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

6.  Different expression of CD44, ICAM-1, and HSP60 on primary tumor and metastases of a human pancreatic carcinoma growing in scid mice.

Authors:  P Piselli; S Vendetti; D Vismara; R Cicconi; F Poccia; V Colizzi; A Delpino
Journal:  Anticancer Res       Date:  2000 Mar-Apr       Impact factor: 2.480

7.  Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.

Authors:  Mitsuyuki Arinaga; Tsuyoshi Noguchi; Shinsuke Takeno; Masao Chujo; Takashi Miura; Yuzo Uchida
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

8.  Expression of heat shock protein 70 in grossly resected esophageal squamous cell carcinoma.

Authors:  Tsuyoshi Noguchi; Shinsuke Takeno; Tomotaka Shibata; Yuzo Uchida; Shigeo Yokoyama; Wolfram Müller
Journal:  Ann Thorac Surg       Date:  2002-07       Impact factor: 4.330

9.  Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site.

Authors:  Michele S Woo; Yasutaka Ohta; Isaac Rabinovitz; Thomas P Stossel; John Blenis
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  The effect of serum, EGF, PGF2 alpha and insulin on S6 phosphorylation and the initiation of protein and DNA synthesis.

Authors:  G Thomas; J Martin-Pérez; M Siegmann; A M Otto
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

View more
  1 in total

1.  Identification of differentially expressed genes in mouse hepatocarcinoma ascites cell line with low potential of lymphogenous metastasis.

Authors:  Xiao-Nan Cui; Jian-Wu Tang; Li Hou; Bo Song; Li-Ying Ban
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.